| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.21 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |